Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Bourguet

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Expert Opinion on Therapeutic Patents|November 25, 2010
Retinoic acid receptor modulators: a perspective on recent advances and promisesSusana Alvarez, William Bourguet, Hinrich Gronemeyer, et al.
Acta Crystallographica. Section F, Structural Biology Communications|February 5, 2019
A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor αJérôme Eberhardt, Alastair G McEwen, William Bourguet, et al.
Molecular and Cellular Endocrinology|January 24, 2012
SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and βBrenda J Mengeling, Michael L Goodson, William Bourguet, et al.
Cells|November 8, 2019
Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their CombinationsAlbane le Maire, Catherine Teyssier, Patrick Balaguer, et al.
Vitamins and Hormones|January 7, 2014
Nuclear receptor profiling of bisphenol-A and its halogenated analoguesVanessa Delfosse, Marina Grimaldi, Albane le Maire, et al.
Molecular Pharmacology|March 20, 2003
Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogensBéatrice Terouanne, Philippe Nirdé, Fanja Rabenoelina, et al.
Frontiers in Endocrinology|June 2, 2015
Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine DisruptorsMarina Grimaldi, Abdelhay Boulahtouf, Vanessa Delfosse, et al.
Acta Crystallographica. Section F, Structural Biology Communications|February 9, 2025
A two-in-one expression construct for biophysical and structural studies of the human pregnane X receptor ligand-binding domain, a pharmaceutical and environmental targetCoralie Carivenc, Guillaume Laconde, Pauline Blanc, et al.
Frontiers in Neuroscience|June 25, 2015
Reporter cell lines to evaluate the selectivity of chemicals for human and zebrafish estrogen and peroxysome proliferator activated γ receptorsMarina Grimaldi, Abdelhay Boulahtouf, Vanessa Delfosse, et al.
Molecular Endocrinology (Baltimore, Md.)|December 24, 2005
Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actionsVirginie Georget, William Bourguet, Serge Lumbroso, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Expert Opinion on Therapeutic Patents|November 25, 2010
Retinoic acid receptor modulators: a perspective on recent advances and promisesSusana Alvarez, William Bourguet, Hinrich Gronemeyer, et al.
Acta Crystallographica. Section F, Structural Biology Communications|February 5, 2019
A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor αJérôme Eberhardt, Alastair G McEwen, William Bourguet, et al.
Molecular and Cellular Endocrinology|January 24, 2012
SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and βBrenda J Mengeling, Michael L Goodson, William Bourguet, et al.
Cells|November 8, 2019
Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their CombinationsAlbane le Maire, Catherine Teyssier, Patrick Balaguer, et al.
Vitamins and Hormones|January 7, 2014
Nuclear receptor profiling of bisphenol-A and its halogenated analoguesVanessa Delfosse, Marina Grimaldi, Albane le Maire, et al.
Molecular Pharmacology|March 20, 2003
Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogensBéatrice Terouanne, Philippe Nirdé, Fanja Rabenoelina, et al.
Frontiers in Endocrinology|June 2, 2015
Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine DisruptorsMarina Grimaldi, Abdelhay Boulahtouf, Vanessa Delfosse, et al.
Acta Crystallographica. Section F, Structural Biology Communications|February 9, 2025
A two-in-one expression construct for biophysical and structural studies of the human pregnane X receptor ligand-binding domain, a pharmaceutical and environmental targetCoralie Carivenc, Guillaume Laconde, Pauline Blanc, et al.
Frontiers in Neuroscience|June 25, 2015
Reporter cell lines to evaluate the selectivity of chemicals for human and zebrafish estrogen and peroxysome proliferator activated γ receptorsMarina Grimaldi, Abdelhay Boulahtouf, Vanessa Delfosse, et al.
Molecular Endocrinology (Baltimore, Md.)|December 24, 2005
Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actionsVirginie Georget, William Bourguet, Serge Lumbroso, et al.
Pageof 10